Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vancomycin dose adjustment in critically ill adults with sepsis
IRCT201209291497N2Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Oct 2012
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of vancomycin in sepsis, sponsored by Tehran University of Medical Sciences. Started Oct 2012; status: completed.
02
Drugs
vancomycin
03
Conditions
sepsis
Beyond the preview
Go deeper on IRCT201209291497N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201209291497N2.